Is self-harm behavior, such as cutting, present in children with generalized anxiety disorder (GAD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Self-Harm and Cutting in Children with Generalized Anxiety Disorder

Yes, self-harm behaviors including cutting can occur in children with generalized anxiety disorder (GAD), and clinicians must systematically assess for these safety risks at initial evaluation and throughout treatment. 1

Evidence Linking Anxiety to Self-Harm

The American Academy of Child and Adolescent Psychiatry explicitly states that safety risks including self-harm behaviors must be assessed both at initial evaluation and during treatment of anxiety disorders, as these risks are directly associated with anxiety disorders themselves. 1

  • Superficial cutting of the arms or neck is recognized as a common method of self-harm attempt in children and adolescents, alongside ingestions and other methods. 1

  • Among adolescents with anxiety disorders, 24% reported suicidal ideation and 6% made suicide attempts, with generalized anxiety disorder combined with comorbid depression conveying the greatest risk. 1

  • Mood or anxiety disorders are established risk factors for suicide attempts in both genders, with panic attacks in girls specifically increasing risk for suicidal ideation or self-harm attempts. 1

Clinical Assessment Requirements

Gathering information from multiple sources using culturally and developmentally sensitive techniques is necessary when evaluating safety risks in anxious children. 1

The assessment must answer two critical questions: 1

  • Is the patient at current risk for self-harm?
  • Are the patient and family able to adhere to recommendations regarding supervision, safeguarding, and follow-up care?

Psychiatric hospitalization is indicated when the youth actively voices intent to harm themselves, particularly in the context of severe anxiety/agitation, multiple previous self-harm attempts, previous unsuccessful treatment, or caregiver incapacity. 1

Risk Amplification Factors

Several factors increase the likelihood of self-harm in children with GAD:

  • Comorbid depression with GAD creates particularly high-risk scenarios for self-harm and suicidal behavior. 1, 2

  • History of abuse (physical or sexual) increases suicide attempt risk even when controlling for other factors, with 15-20% of female attempters having an abuse history. 1, 2

  • Separation anxiety disorder in particular may suggest the need for exploration of traumatic event exposure, which independently increases self-harm risk. 1

  • Anxiety disorders show heterotypic continuity, meaning untreated childhood anxiety can predict future mood disorders and substance use disorders, which further elevate self-harm risk. 1

Monitoring During Treatment

Treatment with antidepressant medications (SSRIs) for GAD requires systematic tracking of treatment-emergent adverse events including worsening symptoms and emerging suicidal thoughts. 3

  • Reassessment of safety risks should occur at every follow-up visit, not just at initial evaluation. 1

  • Immediate psychiatric referral is required for suicidal ideation, self-harm behaviors, harm to others, psychosis, or severe agitation. 4, 5

Common Clinical Pitfalls

Do not assume that anxiety disorders are "less serious" than mood disorders regarding self-harm risk—anxiety independently increases risk and the combination with depression is particularly dangerous. 1, 2

Do not delay safety assessment until after establishing the full diagnostic picture—safety evaluation must occur immediately at first contact. 1

Do not rely solely on child self-report for safety assessment—information from parents, teachers, and other sources is essential, as children may minimize or not fully understand their own risk. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Understanding the Drivers of Suicidal Behavior

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Assessment and Management of Anxiety Attacks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Anxiety and ADHD in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended treatment for a 33-year-old female patient with moderate Generalized Anxiety Disorder (GAD) symptoms, including excessive worry, anxious thoughts, and fatigue, exacerbated by stress?
What is the recommended antidepressant for a 12-year-old with Generalized Anxiety Disorder (GAD)?
What are the diagnostic criteria and treatment options for Generalized Anxiety Disorder (GAD)?
What are the recommendations for the assessment and management of generalized anxiety disorder?
What is the best daily medication for an adult patient with generalized anxiety disorder (GAD) and no significant medical history?
What medication is suitable for a patient with discrete social anxiety disorder who is nervous about performing at a recital?
What are the applications of robotics in pulmonary rehabilitation for patients with chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) or cystic fibrosis?
What is the recommended analgesia regimen for a patient with H. pylori infection?
In which clinical scenarios is dobutamine preferred for increasing cardiac output and heart rate, particularly in patients with acute decompensated heart failure, cardiogenic shock, or severe left ventricular dysfunction?
What are the indications for albumin administration in patients with hypoalbuminemia due to conditions such as liver disease, nephrotic syndrome, or major surgery?
What is the time cutoff for thrombolytic therapy, such as tPA (tissue plasminogen activator), in the treatment of an MCA (Middle Cerebral Artery) M1 occlusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.